You are here: Welcome to the MPKB » Welcome to the MPKB » Diseases » Co-infections
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
home:diseases:co-infections [06.08.2011] – [Types] paulalberthome:diseases:co-infections [09.14.2022] (current) – external edit 127.0.0.1
Line 1: Line 1:
-~~NOTOC~~ 
  
 ====== Co-infections ====== ====== Co-infections ======
Line 8: Line 7:
 Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, there is a good chance the MP targets these infections. Patients on the MP experience an immunopathological reaction in eliminating any microbes including those labelled as co-infections. Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, there is a good chance the MP targets these infections. Patients on the MP experience an immunopathological reaction in eliminating any microbes including those labelled as co-infections.
  
-===== Types =====+===== Frequently cited types =====
  
   * //**Bartonella**// – A genus of Gram-negative bacteria. Facultative intracellular parasites, //Bartonella// species can infect healthy people but are considered especially important as opportunistic pathogens.   * //**Bartonella**// – A genus of Gram-negative bacteria. Facultative intracellular parasites, //Bartonella// species can infect healthy people but are considered especially important as opportunistic pathogens.
   * //**Borellia**//   * //**Borellia**//
   * //**Babesia**// – //Babesia// is a protozoan parasite of the blood that causes a hemolytic disease known as Babesiosis. There are over 100 species of //Babesia// identified.   * //**Babesia**// – //Babesia// is a protozoan parasite of the blood that causes a hemolytic disease known as Babesiosis. There are over 100 species of //Babesia// identified.
-  * //**Candida albicans**// – //Candida// is a fungus (a form of yeast) that plays a role in opportunistic oral and genital infections in humans. //C. albicans// biofilms readily form on the surface of implantable medical devices. Systemic fungal infections (fungemias) have emerged as important causes of morbidity and mortality in patients traditionally labelled as immunocompromised, e.g., AIDS, cancer chemotherapy, organ or bone marrow transplantation. According to the Marshall Pathogenesis, patients suffering from chronic diseases are also immunocompromised. //See article [[home:othertreatments:antifungals|antifungal agents]]//. 
   * **Cytomegalovirus** – A viral genus of the viral group known as Herpesviridae or herpesviruses. It is typically abbreviated as CMV. The species that infects humans it is commonly known as human CMV (HCMV) or human herpesvirus-5 (HHV-5), and is the best studied of all cytomegaloviruses.   * **Cytomegalovirus** – A viral genus of the viral group known as Herpesviridae or herpesviruses. It is typically abbreviated as CMV. The species that infects humans it is commonly known as human CMV (HCMV) or human herpesvirus-5 (HHV-5), and is the best studied of all cytomegaloviruses.
   * //**Ehrlicha**// – A genus of rickettsiales bacteria typically transmitted by ticks.    * //**Ehrlicha**// – A genus of rickettsiales bacteria typically transmitted by ticks. 
   * **Epstein-Barr virus**   * **Epstein-Barr virus**
   * //**Rickettsia**// – A genus of non-motile, Gram-negative, non-sporeforming, highly pleomorphic bacteria that can present as cocci (0.1 μm in diameter), rods (1–4 μm long) or thread-like (10 μm long).    * //**Rickettsia**// – A genus of non-motile, Gram-negative, non-sporeforming, highly pleomorphic bacteria that can present as cocci (0.1 μm in diameter), rods (1–4 μm long) or thread-like (10 μm long). 
 +
 +
 +==== Candida albicans ====
 +
 +<relatedarticle> [[home:othertreatments:antifungals|Antifungal agents]] </article>
 +
 +//Candida albicans// is a fungus (a form of yeast) that plays a role in opportunistic oral and genital infections in humans. //C. albicans// biofilms readily form on the surface of implantable medical devices. Systemic fungal infections (fungemias) have emerged as important causes of morbidity and mortality in patients traditionally labelled as immunocompromised, e.g., AIDS, cancer chemotherapy, organ or bone marrow transplantation.  (According to the Marshall Pathogenesis, patients suffering from chronic inflammatory diseases are likewise immunocompromised.) 
 +
 +Extrapolating to humans, these findings suggest that coconut oil could become the first dietary intervention to reduce C. albicans GI colonization.  [[https://msphere.asm.org/content/1/1/e00020-15|Dietary coconut oil also altered the metabolic program of colonizing C. albicans cells.]]
 +
 +
 +
 +As the section devoted to antimicrobial peptides (AmPs) explains, the AmP cathelicidin is a component of the innate immune system, and is responsive to fungi.(({{pmid>long:19817855}}))
 +
 +Antifungal agents such as fluconazole (Diflucan) are sometimes prescribed to treat fungal infections. While some patients have reported feeling better after taking antifungal agents, antifungals interfere with immune function.
 +
 +At least according to one study, patients are a poor judge of whether they have fungal infections.
 +
 +<blockquote>
 +Patient symptom scores were a poor predictor of yeast infections based on yeast culture results. ... Self-reported symptoms are not reliable for diagnosis.
 +
 +//**Susan Hoffstetter** et al.// (({{pmid>long:18664056}})) </blockquote> 
 +
 +
 ===== Term can be ambiguous ===== ===== Term can be ambiguous =====
  
Line 24: Line 46:
 In parasitology, a coinfection is defined as the simultaneous infection of a host by multiple pathogens with one pathogen being the primary disease-causing agent. The term is something of a legacy of Koch's postulates in which infectious diseases are only caused by a single species of microbe.  In parasitology, a coinfection is defined as the simultaneous infection of a host by multiple pathogens with one pathogen being the primary disease-causing agent. The term is something of a legacy of Koch's postulates in which infectious diseases are only caused by a single species of microbe. 
  
-According to the Marshall Pathogenesis, however, pointing to a single microbe as being the cause of disease and the rest as largely ancillary does not adequately represent the complexity of successive infection and the role that many microbes, combined, may have in causing disease. Even Epstein-Barr virus, which is the minds of many a classical co-infection, has been show to act directly on the body's nuclear receptors including the VDR.(({{pubmed>long:19550398}})) A 2011 paper further showed that EBV not only down-regulates expression of the VDR protein itself, but also acts to block transcription by the VDR.(({{pubmed>long:20593215}}))+According to the Marshall Pathogenesis, however, pointing to a single microbe as being the cause of disease and the rest as largely ancillary does not adequately represent the complexity of successive infection and the role that many microbes, combined, may have in causing disease. Even Epstein-Barr virus, which is the minds of many a classical co-infection, has been show to act directly on the body's nuclear receptors including the VDR.(({{pmid>long:19550398}})) A 2011 paper further showed that EBV not only down-regulates expression of the VDR protein itself, but also acts to block transcription by the VDR.(({{pmid>long:20593215}}))
  
  
Line 30: Line 52:
  
 <relatedarticle> [[home:pathogenesis:innate_immunity|Innate immune response and Th1 inflammation]]  </article> <relatedarticle> [[home:pathogenesis:innate_immunity|Innate immune response and Th1 inflammation]]  </article>
 +
 +
 +<blockquote>
 +I used to think that herpes erupted when immunity was down but I have now witnessed too many shingles outbreaks in Marshall Protocol patients as they recovered. Called IRIS or Immune Recovery Inflammatory Syndrome, this is also seen in AIDS patients as their immunity recovers. 
 +
 +//**Greg Blaney, M.D.**//</blockquote>
 +
 +
 +
 +
  
 Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes including "co-infections." One important component of the innate immune response is the antimicrobial peptides. Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes including "co-infections." One important component of the innate immune response is the antimicrobial peptides.
Line 35: Line 67:
  
 {{section>:home:pathogenesis:innate_immunity#antimicrobial_peptides_target_fungi_and_viruses&noheader}} {{section>:home:pathogenesis:innate_immunity#antimicrobial_peptides_target_fungi_and_viruses&noheader}}
 +
 +
 +Some evidence has emerged that using a therapy to target a given infection aids the body in its ability to eliminate otherwise unrelated pathogens. For example, a 2011 //Science// study gave two groups of mice an injection of poliovirus, a gut virus. One group was treated with antibiotics, thus depleting their intestinal microbiome. This group was less susceptible to poliovirus disease and supported minimal viral replication in the intestine. Further, the pathogenesis of reovirus, an unrelated gut virus, was also more severe in the presence of intestinal microbes.(({{pmid>long:2199839}}))
 +
 +
  
  
Line 40: Line 77:
 {{tag>diseases}} {{tag>diseases}}
  
 +<nodisp>
 ===== Notes and comments ===== ===== Notes and comments =====
  
Line 45: Line 83:
  
  
-===== References =====+===== References =====</nodisp> 
home/diseases/co-infections.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.